Updated Jul 16, 2026
Keenan Greg is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $210K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-10 | AUPH | Aurinia Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 8.1K | $14.32 | $116K |
| 2026-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | A — Grant or award | 40.6K | $0.00 | |
| 2026-02-03 | AUPH | Aurinia Pharmaceuticals Inc. | F — Tax withholding / forfeiture | 11.6K | $14.53 | $168K |
| 2025-08-01 | AUPH | Aurinia Pharmaceuticals Inc. | S — Open-market sale | 20.0K | $10.50 | $210K |
Keenan Greg is a corporate insider — currently tracked as SVP, Chief Medical Officer. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($210K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Keenan Greg profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.